Kidney patients needed for drug dosing study
NCT ID NCT07137689
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times
Summary
This study looked at how the drug LY3537982 moves through the body in people with different levels of kidney function. Researchers compared 32 participants with normal kidneys to those with moderate or severe kidney problems. The goal was to find the right dose for people with kidney issues. The study lasted about 43 days per person.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Genesis Clinical Research
Tampa, Florida, 33603, United States
-
Jacksonville Center for Clinical Research
Jacksonville, Florida, 32216, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
-
Panax Clinical Research
Miami Lakes, Florida, 33014, United States
Conditions
Explore the condition pages connected to this study.